Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.14 trillion and total revenue of $111.45 billion.
Market Cap
1.14T
Revenue
111.45B
Profits
-41.03B
PE Ratio
n/a
Profit Margin
-36.81%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.42B | 0.88% | 51,902 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.95B | 0.59% | 26,599 | 14.92B |
| 3 | ARGX | argenx SE | 50.65B | -0.31% | 52,035 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.84B | 2.14% | 28,864 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 35.40B | 2.46% | 74,225 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.47B | -0.56% | 70,994 | - |
| 7 | RPRX | Royalty Pharma plc | 29.60B | -0.46% | 140,697 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.92B | 6.23% | 466,141 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.73B | 0.51% | 40,494 | 3.23B |
| 10 | MRNA | Moderna, Inc. | 21.14B | 0.76% | 1,261,523 | 2.23B |
| 11 | ROIV | Roivant Sciences Ltd. | 21.03B | 1.48% | 256,141 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.78B | -1.30% | 41,481 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.06B | 2.90% | 458,682 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.22B | 2.65% | 47,899 | 998.25M |
| 15 | SMMT | Summit Therapeutics Inc. | 14.55B | 0.48% | 260,637 | - |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 14.15B | 0.89% | 35,796 | 4.44B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.86B | 1.50% | 97,422 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.60B | 1.17% | 42,204 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.32B | -1.39% | 218,351 | 2.38B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.53B | 0.64% | 25,420 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.13B | 1.63% | 141,624 | 622.01M |
| 22 | AXSM | Axsome Therapeutics, Inc. | 11.12B | -0.22% | 23,488 | 708.24M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.19B | 0.26% | 119,427 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.71B | -0.04% | 145,746 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.26B | -0.21% | 119,000 | 105.82M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.25B | 0.30% | 20,841 | 417.30M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 9.19B | -0.62% | 9,834 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.46B | 7.53% | 746,908 | 1.51B |
| 29 | IBRX | ImmunityBio, Inc. | 8.42B | -0.86% | 1,250,891 | 140.98M |
| 30 | NUVL | Nuvalent, Inc. | 8.21B | -0.64% | 9,172 | - |
| 31 | PCVX | Vaxcyte, Inc. | 7.74B | -0.74% | 61,789 | - |
| 32 | TECH | Bio-Techne Corporation | 7.49B | 0.86% | 61,381 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.91B | -0.10% | 36,691 | 51.48M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 6.63B | -0.43% | 24,011 | 74.06M |
| 35 | MIRM | Mirum Pharmaceuticals, Inc. | 6.58B | 1.58% | 6,176 | 569.61M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.54B | -1.41% | 82,051 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.37B | 0.50% | 21,011 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.23B | -2.25% | 165,167 | 827.11M |
| 39 | TGTX | TG Therapeutics, Inc. | 6.20B | 1.39% | 153,952 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.16B | 2.87% | 36,874 | 217.17M |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.03% | 21,945 | 15.00M |
| 42 | CGON | CG Oncology, Inc. | 6.12B | 0.10% | 17,175 | 5.07M |
| 43 | CELC | Celcuity Inc. | 6.04B | -0.54% | 40,642 | - |
| 44 | IMVT | Immunovant, Inc. | 5.94B | 0.48% | 74,735 | - |
| 45 | BLTE | Belite Bio, Inc | 5.92B | -0.98% | 5,528 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.79B | -0.14% | 55,913 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.78B | -0.91% | 37,459 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.47B | -0.53% | 23,680 | 769.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.37B | -0.39% | 22,228 | 7.50M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | 0.04% | 777,768 | 1.11B |
| 51 | CRSP | CRISPR Therapeutics AG | 5.16B | -1.02% | 115,470 | 4.10M |
| 52 | CAI | Caris Life Sciences, Inc. | 4.73B | 5.08% | 287,528 | 907.29M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.72B | -0.84% | 5,674 | 1.34M |
| 54 | LEGN | Legend Biotech Corporation | 4.65B | -1.64% | 346,141 | 1.14B |
| 55 | MANE | Veradermics, Incorporated | 4.53B | 1.73% | 27,607 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.48B | -1.52% | 153,223 | 22.57M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.38B | -0.88% | 8,483 | 274.48M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.00B | -1.06% | 126,833 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.90B | 1.23% | 44,285 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.83B | -2.56% | 55,185 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 0.03% | 350,183 | 596.96M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | -0.28% | 68,546 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.71B | -0.29% | 105,307 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.65B | -0.79% | 125,382 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.55B | -4.34% | 18,846 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.32B | -2.04% | 186,058 | 62.38M |
| 67 | ERAS | Erasca, Inc. | 3.20B | -1.58% | 336,345 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 3.14B | 0.66% | 125,169 | - |
| 69 | BEAM | Beam Therapeutics Inc. | 3.09B | -2.33% | 100,228 | 164.01M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.05B | -2.33% | 47,666 | 236.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.03B | -0.70% | 53,856 | - |
| 72 | ALMS | Alumis Inc. | 3.00B | -0.42% | 55,889 | 24.05M |
| 73 | KLRA | Kailera Therapeutics, Inc. | 2.95B | -0.61% | 56,223 | - |
| 74 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.04% | 179,147 | 285.01M |
| 75 | GPCR | Structure Therapeutics Inc. | 2.70B | -0.70% | 39,464 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.68B | 1.28% | 26,251 | - |
| 77 | VERA | Vera Therapeutics, Inc. | 2.66B | 1.04% | 30,497 | - |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | -0.33% | 44,219 | 415.62M |
| 79 | NKTR | Nektar Therapeutics | 2.63B | -0.91% | 63,095 | 55.63M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | 2.20% | 12,672 | 535.08M |
| 81 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 0.49% | 49,142 | 670.00M |
| 82 | IMNM | Immunome, Inc. | 2.56B | -1.74% | 37,294 | 6.94M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.54B | 0.06% | 21,985 | 865.00K |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.49B | 3.40% | 19,623 | - |
| 85 | RLAY | Relay Therapeutics, Inc. | 2.45B | -0.31% | 83,892 | 10.68M |
| 86 | IDYA | IDEAYA Biosciences, Inc. | 2.45B | -0.75% | 28,066 | 225.27M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.42B | -1.14% | 10,709 | - |
| 88 | NBTX | Nanobiotix S.A. | 2.41B | -11.82% | 37,520 | 38.27M |
| 89 | KOD | Kodiak Sciences Inc. | 2.41B | -3.19% | 58,111 | - |
| 90 | DFTX | Definium Therapeutics, Inc. | 2.32B | -0.47% | 111,438 | - |
| 91 | ZLAB | Zai Lab Limited | 2.19B | -0.66% | 104,527 | 453.28M |
| 92 | TRVI | Trevi Therapeutics, Inc. | 2.14B | 1.34% | 43,029 | - |
| 93 | STOK | Stoke Therapeutics, Inc. | 2.04B | 0.34% | 10,084 | 32.08M |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | -1.80% | 169,721 | 2.18B |
| 95 | TYRA | Tyra Biosciences, Inc. | 2.01B | -0.62% | 18,407 | - |
| 96 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -1.29% | 148,794 | 52.04M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.15% | 210,763 | 298.30M |
| 98 | AAPG | Ascentage Pharma Group International | 1.98B | 0.37% | 25 | 82.08M |
| 99 | NTLA | Intellia Therapeutics, Inc. | 1.97B | -2.15% | 682,135 | 66.09M |
| 100 | ANAB | AnaptysBio, Inc. | 1.95B | - | 4,840 | 234.60M |
| 101 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -0.73% | 83,516 | 7.47M |
| 102 | PHVS | Pharvaris N.V. | 1.94B | -0.75% | 13,276 | - |
| 103 | SION | Sionna Therapeutics, Inc. | 1.91B | -8.05% | 41,030 | - |
| 104 | MBX | MBX Biosciences, Inc. | 1.89B | -0.80% | 52,885 | - |
| 105 | ADMA | ADMA Biologics, Inc. | 1.88B | 3.17% | 415,975 | 509.86M |
| 106 | GENB | Generate Biomedicines, Inc. | 1.87B | 2.37% | 5,851 | 30.30M |
| 107 | MESO | Mesoblast Limited | 1.87B | -0.83% | 22,048 | 65.38M |
| 108 | OCS | Oculis Holding AG | 1.86B | -3.49% | 69,604 | 1.40M |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | -1.85% | 67,903 | 217.17M |
| 110 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.25% | 39,234 | 11.13M |
| 111 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -0.26% | 8,863 | 1.20B |
| 112 | VRDN | Viridian Therapeutics, Inc. | 1.76B | -0.87% | 105,399 | 70.92M |
| 113 | ZYME | Zymeworks Inc. | 1.76B | 0.08% | 43,290 | 81.26M |
| 114 | INBX | Inhibrx Biosciences, Inc. | 1.76B | -5.79% | 59,984 | 1.30M |
| 115 | PVLA | Palvella Therapeutics, Inc. | 1.75B | 0.01% | 5,595 | - |
| 116 | RAPP | Rapport Therapeutics, Inc. | 1.74B | -5.57% | 20,977 | 20.00M |
| 117 | QURE | uniQure N.V. | 1.73B | -0.87% | 114,333 | 18.09M |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.70B | -2.62% | 64,460 | 899.11M |
| 119 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -2.45% | 2,287,767 | 66.41M |
| 120 | INVA | Innoviva, Inc. | 1.68B | 1.20% | 9,132 | 420.69M |
| 121 | VCEL | Vericel Corporation | 1.68B | -0.24% | 14,315 | 292.09M |
| 122 | GLUE | Monte Rosa Therapeutics, Inc. | 1.67B | -2.25% | 17,802 | 42.95M |
| 123 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | 0.43% | 28,242 | 66.05M |
| 124 | NRIX | Nurix Therapeutics, Inc. | 1.67B | -1.07% | 38,567 | 71.78M |
| 125 | NUVB | Nuvation Bio Inc. | 1.66B | 0.42% | 218,521 | 143.05M |
| 126 | ARDX | Ardelyx, Inc. | 1.64B | 0.30% | 125,217 | 427.68M |
| 127 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | -3.92% | 1,770,300 | 285.61M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.57B | 0.05% | 78,935 | 65.50M |
| 129 | NVAX | Novavax, Inc. | 1.56B | 0.11% | 567,129 | 596.34M |
| 130 | IMTX | Immatics N.V. | 1.54B | -0.78% | 27,331 | 56.67M |
| 131 | ATAI | AtaiBeckley Inc. | 1.48B | 0.12% | 342,160 | 4.09M |
| 132 | DMRA | Damora Therapeutics, Inc. | 1.48B | 0.53% | 6,212 | - |
| 133 | URGN | UroGen Pharma Ltd. | 1.48B | -3.26% | 45,682 | 140.49M |
| 134 | PGEN | Precigen, Inc. | 1.47B | -1.07% | 143,106 | 9.68M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.47B | -2.49% | 17,327 | - |
| 136 | IMCR | Immunocore Holdings plc | 1.46B | -0.73% | 6,821 | 412.81M |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.04% | 649,452 | 73.62M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.40B | -0.51% | 16,182 | 2.50M |
| 139 | ABCL | AbCellera Biologics Inc. | 1.39B | -13.33% | 3,645,037 | 79.21M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.37B | 0.99% | 193,074 | 71.80M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.37B | -0.19% | 111,974 | - |
| 142 | BHVN | Biohaven Ltd. | 1.36B | -0.44% | 94,063 | - |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.36B | -0.47% | 5,405 | - |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 1.71% | 61,008 | - |
| 145 | FTRE | Fortrea Holdings Inc. | 1.35B | -5.14% | 146,464 | 2.71B |
| 146 | GHRS | GH Research PLC | 1.32B | - | 5,761 | - |
| 147 | SVRA | Savara Inc. | 1.31B | 0.59% | 59,969 | - |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.28B | -4.72% | 49,015 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.39% | 6,899 | - |
| 150 | OLMA | Olema Pharmaceuticals, Inc. | 1.25B | -3.57% | 77,024 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.23B | 0.56% | 40,595 | - |
| 152 | IVA | Inventiva S.A. | 1.23B | -0.34% | 3,965 | 7.94M |
| 153 | DBVT | DBV Technologies S.A. | 1.22B | 1.96% | 19,038 | 5.74M |
| 154 | ZBIO | Zenas BioPharma, Inc. | 1.21B | -0.29% | 12,099 | 10.00M |
| 155 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.21B | -1.48% | 118,033 | 204.73M |
| 156 | EYPT | EyePoint, Inc. | 1.16B | -0.93% | 32,891 | 7.61M |
| 157 | SEPN | Septerna, Inc. | 1.14B | 8.02% | 20,956 | 72.26M |
| 158 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | 1.52% | 5,250 | - |
| 159 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | 8.23% | 1,137,719 | 69.64M |
| 160 | MNKD | MannKind Corporation | 1.05B | 1.04% | 476,183 | 360.78M |
| 161 | OMER | Omeros Corporation | 1.04B | 0.70% | 71,618 | - |
| 162 | AKTS | Aktis Oncology, Inc. | 1.01B | 0.16% | 4,185 | 8.28M |
| 163 | DSGN | Design Therapeutics, Inc. | 973.70M | -0.13% | 22,110 | - |
| 164 | SLS | SELLAS Life Sciences Group, Inc. | 967.87M | -0.10% | 385,799 | - |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 964.28M | -0.65% | 47,890 | 204.89M |
| 166 | SANA | Sana Biotechnology, Inc. | 958.76M | -2.95% | 246,504 | - |
| 167 | XNCR | Xencor, Inc. | 957.17M | 0.94% | 54,641 | 97.36M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 947.19M | 1.78% | 181,636 | - |
| 169 | LBRX | LB Pharmaceuticals Inc | 934.83M | -0.29% | 1,195 | - |
| 170 | CGEM | Cullinan Therapeutics, Inc. | 921.26M | 1.77% | 52,702 | - |
| 171 | PHAR | Pharming Group N.V. | 920.47M | 2.98% | 1,970 | 369.49M |
| 172 | GERN | Geron Corporation | 914.17M | 2.52% | 1,720,151 | 196.12M |
| 173 | ANNX | Annexon, Inc. | 909.33M | -2.29% | 81,215 | - |
| 174 | MGTX | MeiraGTx Holdings plc | 897.96M | -2.02% | 22,274 | 81.39M |
| 175 | VOR | Vor Biopharma Inc. | 891.36M | -4.64% | 150,372 | - |
| 176 | JANX | Janux Therapeutics, Inc. | 875.13M | 0.84% | 39,994 | 13.73M |
| 177 | ABSI | Absci Corporation | 866.83M | -3.81% | 411,965 | 1.84M |
| 178 | DRTS | Alpha Tau Medical Ltd. | 864.26M | -5.03% | 226,216 | - |
| 179 | ANRO | Alto Neuroscience, Inc. | 859.84M | - | 12,142 | - |
| 180 | CTMX | CytomX Therapeutics, Inc. | 851.18M | 1.30% | 128,242 | 35.54M |
| 181 | TBPH | Theravance Biopharma, Inc. | 850.11M | -0.18% | 18,457 | 109.78M |
| 182 | ABUS | Arbutus Biopharma Corporation | 849.79M | -1.71% | 51,894 | 14.08M |
| 183 | KURA | Kura Oncology, Inc. | 845.02M | 0.11% | 155,968 | 67.48M |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 842.07M | -1.40% | 105,156 | 84.28M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 836.91M | -1.06% | 854 | - |
| 186 | EVMN | Evommune, Inc. | 832.74M | -0.39% | 31,411 | 10.00M |
| 187 | ODTX | Odyssey Therapeutics, Inc. | 831.21M | 0.97% | 14,920 | 2.98M |
| 188 | AURA | Aura Biosciences, Inc. | 818.91M | -3.66% | 47,564 | - |
| 189 | SPTX | Seaport Therapeutics, Inc. | 814.51M | 0.72% | 3,239 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 805.58M | 1.43% | 5,597 | - |
| 191 | ALLO | Allogene Therapeutics, Inc. | 794.59M | 1.32% | 245,982 | 22.00K |
| 192 | RLMD | Relmada Therapeutics, Inc. | 754.15M | -2.31% | 456,753 | - |
| 193 | SLDB | Solid Biosciences Inc. | 734.16M | -2.86% | 47,104 | - |
| 194 | TENX | Tenax Therapeutics, Inc. | 710.07M | 0.92% | 55,163 | - |
| 195 | ACRS | Aclaris Therapeutics, Inc. | 684.35M | -1.01% | 29,238 | 8.37M |
| 196 | FBRX | Forte Biosciences, Inc. | 664.85M | 0.83% | 19,510 | - |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 656.77M | 2.87% | 165,532 | 122.29M |
| 198 | TRAX | First Tracks Biotherapeutics, Inc. | 649.63M | -0.35% | 18,449 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 647.37M | -0.07% | 3,226 | 117.05M |
| 200 | STRO | Sutro Biopharma, Inc. | 645.82M | -0.84% | 4,646 | 102.48M |
| 201 | CADL | Candel Therapeutics, Inc. | 639.65M | -1.36% | 255,158 | - |
| 202 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 621.05M | -1.65% | 19,517 | - |
| 203 | CABA | Cabaletta Bio, Inc. | 614.70M | -1.31% | 148,456 | - |
| 204 | AGMB | AgomAb Therapeutics NV | 612.64M | 2.13% | 3,532 | - |
| 205 | VALN | Valneva SE | 611.89M | -6.51% | 4,493 | 205.07M |
| 206 | ARVN | Arvinas, Inc. | 601.98M | -3.42% | 342,098 | 89.40M |
| 207 | KYTX | Kyverna Therapeutics, Inc. | 601.67M | -3.87% | 75,745 | - |
| 208 | CBIO | Crescent Biopharma, Inc. | 598.46M | -2.75% | 5,112 | 11.88M |
| 209 | ALT | Altimmune, Inc. | 594.25M | -0.97% | 165,096 | 41.00K |
| 210 | CRMD | CorMedix Inc. | 593.81M | -1.17% | 150,914 | 311.71M |
| 211 | PRME | Prime Medicine, Inc. | 577.98M | -1.23% | 194,969 | 4.03M |
| 212 | EIKN | Eikon Therapeutics, Inc. | 576.58M | 7.04% | 48,618 | - |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 567.67M | 0.23% | 119,561 | 151.40M |
| 214 | FDMT | 4D Molecular Therapeutics, Inc. | 562.49M | -0.28% | 27,041 | 88.24M |
| 215 | RIGL | Rigel Pharmaceuticals, Inc. | 559.69M | 15.46% | 227,035 | 299.77M |
| 216 | AVTX | Avalo Therapeutics, Inc. | 555.66M | 2.72% | 22,856 | 59.00K |
| 217 | PROK | ProKidney Corp. | 535.98M | 0.28% | 48,982 | 893.00K |
| 218 | STTK | Shattuck Labs, Inc. | 527.56M | -0.57% | 60,392 | 1.00M |
| 219 | MDXG | MiMedx Group, Inc. | 525.78M | -0.84% | 71,043 | 389.42M |
| 220 | CLYM | Climb Bio, Inc. | 525.45M | -1.08% | 41,355 | - |
| 221 | IMMX | Immix Biopharma, Inc. | 520.05M | -1.11% | 34,143 | - |
| 222 | ANL | Adlai Nortye Ltd. | 518.00M | -0.08% | 4,805 | 5.00M |
| 223 | RGNX | REGENXBIO Inc. | 513.59M | -1.29% | 65,509 | 170.44M |
| 224 | TECX | Tectonic Therapeutic, Inc. | 512.49M | -1.31% | 17,411 | - |
| 225 | OCGN | Ocugen, Inc. | 507.77M | 1.35% | 681,834 | 4.47M |
| 226 | PRTA | Prothena Corporation plc | 506.26M | - | 27,498 | 57.94M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 501.80M | -1.54% | 6,907 | - |
| 228 | XOMA | XOMA Royalty Corporation | 497.01M | 0.51% | 5,168 | 52.15M |
| 229 | UPB | Upstream Bio, Inc. | 490.32M | -1.10% | 23,434 | 2.85M |
| 230 | PRLD | Prelude Therapeutics Incorporated | 485.79M | 0.63% | 43,544 | 12.14M |
| 231 | ASMB | Assembly Biosciences, Inc. | 485.04M | 0.36% | 6,514 | 71.10M |
| 232 | LXEO | Lexeo Therapeutics, Inc. | 478.98M | -0.33% | 52,720 | - |
| 233 | NGNE | Neurogene Inc. | 478.78M | -0.74% | 2,139 | 925.00K |
| 234 | OVID | Ovid Therapeutics Inc. | 471.53M | -2.33% | 274,733 | 7.25M |
| 235 | FULC | Fulcrum Therapeutics, Inc. | 469.76M | 0.71% | 87,302 | 80.00M |
| 236 | SGMT | Sagimet Biosciences Inc. | 465.61M | -1.95% | 55,164 | - |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.40M | -0.27% | 1,285 | - |
| 238 | ZURA | Zura Bio Limited | 450.21M | -0.11% | 4,225 | - |
| 239 | LYEL | Lyell Immunopharma, Inc. | 443.78M | -0.94% | 1,979 | 31.00K |
| 240 | ADCT | ADC Therapeutics SA | 440.08M | -0.57% | 31,115 | 79.18M |
| 241 | MNPR | Monopar Therapeutics Inc. | 438.34M | -0.03% | 4,278 | - |
| 242 | PRTC | PureTech Health plc | 437.17M | -2.58% | 1,042 | 4.66M |
| 243 | AVIR | Atea Pharmaceuticals, Inc. | 430.55M | -0.55% | 10,535 | - |
| 244 | VSTM | Verastem, Inc. | 429.70M | 0.20% | 213,908 | 49.59M |
| 245 | IVVD | Invivyd, Inc. | 427.03M | - | 133,311 | 53.43M |
| 246 | LRMR | Larimar Therapeutics, Inc. | 423.84M | -0.24% | 43,068 | - |
| 247 | BNTC | Benitec Biopharma Inc. | 416.88M | 0.75% | 5,098 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 414.98M | -7.50% | 32,807 | 69.21M |
| 249 | AUTL | Autolus Therapeutics plc | 412.52M | -1.90% | 143,387 | 75.39M |
| 250 | IPSC | Century Therapeutics, Inc. | 409.40M | -0.87% | 87,905 | 109.16M |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 400.96M | -2.00% | 11,218 | 9.01M |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 390.91M | -0.28% | 128,307 | - |
| 253 | VTVT | vTv Therapeutics Inc. | 390.65M | 3.35% | 5,384 | 17.00K |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 375.85M | -0.32% | 106,645 | 217.78M |
| 255 | NAUT | Nautilus Biotechnology, Inc. | 374.88M | -2.32% | 49,041 | - |
| 256 | YDES | YD Bio Limited | 373.40M | -0.09% | 18 | 510.36K |
| 257 | PBYI | Puma Biotechnology, Inc. | 369.02M | 1.54% | 20,629 | 227.18M |
| 258 | IRD | Opus Genetics, Inc. | 358.44M | -1.95% | 163,211 | 14.20M |
| 259 | NMRA | Neumora Therapeutics, Inc. | 344.37M | 0.80% | 75,658 | - |
| 260 | IKT | Inhibikase Therapeutics, Inc. | 344.31M | -0.49% | 16,404 | 1.00 |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 342.70M | -1.40% | 9,337 | - |
| 262 | CCCC | C4 Therapeutics, Inc. | 339.36M | -2.84% | 149,622 | 35.95M |
| 263 | SLN | Silence Therapeutics plc | 336.78M | -0.56% | 13,889 | 839.00K |
| 264 | IMRX | Immuneering Corporation | 335.78M | -0.19% | 43,148 | - |
| 265 | SRZN | Surrozen, Inc. | 335.41M | -0.27% | 6,153 | 7.49M |
| 266 | CMPX | Compass Therapeutics, Inc. | 334.06M | 1.37% | 431,302 | 850.00K |
| 267 | RZLT | Rezolute, Inc. | 332.39M | 0.95% | 144,042 | - |
| 268 | REPL | Replimune Group, Inc. | 330.29M | 6.95% | 592,011 | - |
| 269 | LCTX | Lineage Cell Therapeutics, Inc. | 329.07M | 0.76% | 121,545 | 14.56M |
| 270 | PALI | Palisade Bio, Inc. | 326.48M | 0.52% | 222,502 | - |
| 271 | GLSI | Greenwich LifeSciences, Inc. | 326.27M | -2.40% | 4,273 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 326.23M | -0.43% | 22,543 | 63.50M |
| 273 | ABEO | Abeona Therapeutics Inc. | 325.94M | -2.22% | 88,096 | 5.82M |
| 274 | ARMP | Armata Pharmaceuticals, Inc. | 325.30M | 0.51% | 10,430 | 4.90M |
| 275 | NGEN | NervGen Pharma Corp. | 311.18M | 0.39% | 8,575 | - |
| 276 | NAGE | Niagen Bioscience, Inc. | 309.67M | -2.51% | 172,196 | 130.42M |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 300.75M | 2.42% | 40,494 | 26.87M |
| 278 | ACHV | Achieve Life Sciences, Inc. | 299.74M | 0.72% | 300,736 | - |
| 279 | EDIT | Editas Medicine, Inc. | 294.70M | -1.63% | 162,997 | 38.69M |
| 280 | NVCT | Nuvectis Pharma, Inc. | 294.17M | 0.27% | 2,303 | - |
| 281 | AVXL | Anavex Life Sciences Corp. | 293.77M | -2.16% | 259,424 | - |
| 282 | ELDN | Eledon Pharmaceuticals, Inc. | 290.95M | 0.26% | 59,632 | - |
| 283 | CLLS | Cellectis S.A. | 288.96M | 0.11% | 945 | 79.59M |
| 284 | TARA | Protara Therapeutics, Inc. | 287.14M | -1.04% | 18,172 | - |
| 285 | ALXO | ALX Oncology Holdings Inc. | 279.88M | - | 22,639 | - |
| 286 | ACIU | AC Immune SA | 277.76M | -1.06% | 82,574 | 4.62M |
| 287 | ARTV | Artiva Biotherapeutics, Inc. | 271.88M | 3.77% | 55,786 | 251.00K |
| 288 | CHRS | Coherus Oncology, Inc. | 271.42M | -9.74% | 705,497 | 46.88M |
| 289 | TRDA | Entrada Therapeutics, Inc. | 266.29M | 5.57% | 25,215 | 5.74M |
| 290 | CGEN | Compugen Ltd. | 260.02M | -4.18% | 62,003 | 72.76M |
| 291 | FHTX | Foghorn Therapeutics Inc. | 257.17M | 1.15% | 5,609 | 28.22M |
| 292 | VYGR | Voyager Therapeutics, Inc. | 256.19M | 2.91% | 56,024 | 36.49M |
| 293 | SABS | SAB Biotherapeutics, Inc. | 255.80M | -2.15% | 153,983 | 114.70K |
| 294 | LENZ | LENZ Therapeutics, Inc. | 255.54M | -18.42% | 739,260 | 20.99M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 255.54M | 1.96% | 13,623 | 1.78M |
| 296 | HELP | Cybin Inc. | 252.68M | -0.98% | 62,186 | - |
| 297 | NERV | Minerva Neurosciences, Inc. | 249.02M | 0.89% | 6,808 | - |
| 298 | FATE | Fate Therapeutics, Inc. | 247.68M | -2.29% | 427,309 | 6.65M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 246.43M | 0.41% | 52,399 | 54.71M |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 245.07M | -0.56% | 707 | 44.64M |
| 301 | ADAG | Adagene Inc. | 243.81M | -2.64% | 2,610 | 7.67M |
| 302 | CDXS | Codexis, Inc. | 240.88M | - | 104,988 | 78.09M |
| 303 | OABI | OmniAb, Inc. | 240.65M | -0.60% | 18,834 | 28.94M |
| 304 | NBP | NovaBridge Biosciences | 239.39M | -1.43% | 108,172 | - |
| 305 | MGNX | MacroGenics, Inc. | 235.17M | 25.42% | 4,806,327 | 149.50M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 233.65M | 0.26% | 192,983 | 1.55M |
| 307 | OBIO | Orchestra BioMed Holdings, Inc. | 232.83M | -0.55% | 7,887 | 33.48M |
| 308 | KROS | Keros Therapeutics, Inc. | 232.70M | -2.08% | 13,762 | 244.06M |
| 309 | SLGL | Sol-Gel Technologies Ltd. | 228.76M | -2.00% | 1,622 | 19.39M |
| 310 | ALEC | Alector, Inc. | 228.71M | 0.49% | 11,325 | 18.42M |
| 311 | NKTX | Nkarta, Inc. | 227.42M | 0.31% | 23,277 | - |
| 312 | CNTX | Context Therapeutics Inc. | 220.51M | 0.42% | 6,676 | - |
| 313 | CAMP | Camp4 Therapeutics Corporation | 214.45M | -6.14% | 1,531 | 3.93M |
| 314 | UNCY | Unicycive Therapeutics, Inc. | 212.53M | 0.13% | 29,452 | - |
| 315 | HUMA | Humacyte, Inc. | 212.03M | -4.50% | 913,141 | 2.04M |
| 316 | MDWD | MediWound Ltd. | 210.52M | -0.49% | 14,103 | 16.96M |
| 317 | TNYA | Tenaya Therapeutics, Inc. | 210.49M | -2.82% | 969,536 | 225.00K |
| 318 | ELTX | Elicio Therapeutics, Inc. | 208.98M | -2.15% | 44,871 | - |
| 319 | RNA | Atrium Therapeutics, Inc. | 206.81M | 0.60% | 16,879 | 18.62M |
| 320 | KPTI | Karyopharm Therapeutics Inc. | 203.45M | 2.44% | 12,141 | 146.07M |
| 321 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 203.17M | 3.76% | 31,108 | - |
| 322 | DTIL | Precision BioSciences, Inc. | 198.94M | -1.91% | 10,586 | 45.07M |
| 323 | CRBU | Caribou Biosciences, Inc. | 194.55M | -2.46% | 188,678 | 11.20M |
| 324 | TLSA | Tiziana Life Sciences Ltd | 193.99M | -0.65% | 25,219 | - |
| 325 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.77M | -4.32% | 80,840 | 17.56M |
| 326 | WHWK | Whitehawk Therapeutics, Inc. | 187.33M | -0.26% | 1,509 | 7.15M |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 184.90M | -0.39% | 14,712 | - |
| 328 | CNTN | Canton Strategic Holdings, Inc. | 184.13M | 1.88% | 72,914 | - |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 183.63M | -1.73% | 21,102 | 2.00M |
| 330 | HRTX | Heron Therapeutics, Inc. | 183.62M | 1.55% | 426,988 | 150.71M |
| 331 | IFRX | InflaRx N.V. | 177.12M | -2.00% | 32,844 | 33.82K |
| 332 | ENLV | Enlivex Ltd. | 176.47M | -1.49% | 22,296 | - |
| 333 | PRQR | ProQR Therapeutics N.V. | 168.58M | -0.62% | 49,598 | 19.19M |
| 334 | PYXS | Pyxis Oncology, Inc. | 167.82M | -2.91% | 24,093 | 13.86M |
| 335 | ANTX | AN2 Therapeutics, Inc. | 167.56M | -1.38% | 8,044 | - |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 165.60M | -1.70% | 105,162 | 70.00M |
| 337 | IMUX | Immunic, Inc. | 163.20M | - | 7,483 | - |
| 338 | KRRO | Korro Bio, Inc. | 162.69M | -1.57% | 8,054 | 3.84M |
| 339 | PLYX | Polaryx Therapeutics, Inc. | 160.97M | 0.29% | 8,081 | - |
| 340 | KZIA | Kazia Therapeutics Limited | 158.83M | -1.42% | 7,611 | 1.27M |
| 341 | MENS | Jyong Biotech Ltd. | 156.11M | -1.93% | 3,528 | - |
| 342 | PLX | Protalix BioTherapeutics, Inc. | 154.29M | -1.29% | 27,122 | 52.74M |
| 343 | MOLN | Molecular Partners AG | 153.08M | -0.24% | 477 | 856.30K |
| 344 | HURA | TuHURA Biosciences, Inc. | 152.59M | - | 14,503 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 150.65M | -1.15% | 4,891 | 697.00K |
| 346 | SPRO | Spero Therapeutics, Inc. | 146.20M | -0.98% | 14,815 | 66.80M |
| 347 | GALT | Galectin Therapeutics Inc. | 146.14M | 0.45% | 46,901 | - |
| 348 | ALPS | Alps Group Inc | 140.44M | 2.29% | 518 | 3.74M |
| 349 | EQ | Equillium, Inc. | 139.73M | -1.78% | 7,609 | 4.39M |
| 350 | IPHA | Innate Pharma S.A. | 139.54M | - | 2 | 10.57M |
| 351 | OKUR | OnKure Therapeutics, Inc. | 139.16M | 0.15% | 13,576 | - |
| 352 | EDSA | Edesa Biotech, Inc. | 138.08M | 1.70% | 26,415 | - |
| 353 | NTHI | NeOnc Technologies Holdings, Inc. | 136.53M | -1.45% | 10,628 | 39.99K |
| 354 | CNTB | Connect Biopharma Holdings Limited | 134.52M | 1.71% | 593 | 64.00K |
| 355 | ACOG | Alpha Cognition Inc. | 129.77M | 0.17% | 783 | 10.22M |
| 356 | VRCA | Verrica Pharmaceuticals Inc. | 126.61M | -0.41% | 318 | 35.58M |
| 357 | GNLX | Genelux Corporation | 126.57M | -1.72% | 6,739 | 8.00K |
| 358 | AGEN | Agenus Inc. | 124.99M | -0.15% | 90,376 | 123.87M |
| 359 | GUTS | Fractyl Health, Inc. | 124.70M | 2.21% | 425,628 | 3.00K |
| 360 | AARD | Aardvark Therapeutics, Inc. | 121.63M | -2.53% | 4,307 | - |
| 361 | PEPG | PepGen Inc. | 116.20M | -1.18% | 229,512 | - |
| 362 | INO | Inovio Pharmaceuticals, Inc. | 113.89M | -2.80% | 518,846 | 65.34K |
| 363 | TTRX | Turn Therapeutics Inc. | 113.49M | -1.80% | 10,730 | - |
| 364 | BMEA | Biomea Fusion, Inc. | 113.15M | -0.32% | 83,438 | - |
| 365 | CRDF | Cardiff Oncology, Inc. | 110.76M | -0.61% | 77,086 | 593.00K |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 108.98M | 0.21% | 2,468 | - |
| 367 | CBUS | Cibus, Inc. | 104.89M | -0.36% | 28,307 | 3.64M |
| 368 | CUE | Cue Biopharma, Inc. | 104.66M | 2.65% | 11,735 | 27.47M |
| 369 | ALDX | Aldeyra Therapeutics, Inc. | 103.75M | -2.27% | 80,073 | - |
| 370 | VANI | Vivani Medical, Inc. | 103.48M | - | 6,277 | - |
| 371 | SEER | Seer, Inc. | 103.25M | - | 613 | 16.58M |
| 372 | ONCY | Oncolytics Biotech Inc. | 102.89M | -1.95% | 19,709 | - |
| 373 | RANI | Rani Therapeutics Holdings, Inc. | 102.81M | -3.74% | 129,837 | 1.63M |
| 374 | CGTX | Cognition Therapeutics, Inc. | 102.76M | -2.54% | 76,295 | - |
| 375 | ANIX | Anixa Biosciences, Inc. | 98.91M | -2.64% | 8,787 | - |
| 376 | ENGN | enGene Therapeutics Inc. | 97.80M | -2.01% | 364,153 | - |
| 377 | LONA | LeonaBio, Inc. | 97.37M | 3.56% | 1,156 | - |
| 378 | NRXS | NeurAxis, Inc. | 97.22M | 3.68% | 29,147 | 3.57M |
| 379 | PMN | ProMIS Neurosciences, Inc. | 95.77M | 0.54% | 416 | - |
| 380 | COYA | Coya Therapeutics, Inc. | 93.83M | -4.31% | 264,564 | 7.95M |
| 381 | NRXP | NRx Pharmaceuticals, Inc. | 92.17M | -1.06% | 160,089 | 1.23M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 91.87M | 1.97% | 818 | 16.80M |
| 383 | RNTX | Rein Therapeutics Inc. | 87.79M | -2.17% | 41,133 | - |
| 384 | QTTB | Q32 Bio Inc. | 87.66M | -0.19% | 6,277 | 53.74M |
| 385 | OKYO | OKYO Pharma Limited | 86.59M | - | 4,628 | - |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 85.12M | 13.90% | 194,243 | 120.77M |
| 387 | EXOZ | eXoZymes, Inc. | 84.92M | 2.19% | 300 | -700.00 |
| 388 | ACET | Adicet Bio, Inc. | 83.90M | -2.20% | 13,272 | - |
| 389 | CSBR | Champions Oncology, Inc. | 83.46M | -0.58% | 55 | 57.95M |
| 390 | PYPD | PolyPid Ltd. | 82.06M | -0.92% | 12,297 | - |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 80.89M | -1.05% | 29,002 | - |
| 392 | ANVS | Annovis Bio, Inc. | 80.81M | -2.09% | 193,568 | - |
| 393 | ATHE | Alterity Therapeutics Limited | 78.94M | -1.67% | 304 | 4.43M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 78.27M | -1.53% | 105,201 | - |
| 395 | GANX | Gain Therapeutics, Inc. | 77.68M | 0.07% | 44,075 | - |
| 396 | XBIT | XBiotech Inc. | 76.98M | 2.23% | 2,261 | - |
| 397 | GOSS | Gossamer Bio, Inc. | 76.86M | -3.31% | 305,646 | 48.47M |
| 398 | ICCC | ImmuCell Corporation | 76.37M | -0.09% | 341 | 27.64M |
| 399 | MCRB | Seres Therapeutics, Inc. | 76.29M | 1.02% | 1,720 | 1.15M |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 75.46M | 1.80% | 34,507 | - |
| 401 | PLRX | Pliant Therapeutics, Inc. | 74.92M | 0.83% | 25,424 | - |
| 402 | FBIO | Fortress Biotech, Inc. | 73.08M | -1.79% | 19,851 | 63.26M |
| 403 | RLYB | Rallybio Corporation | 73.00M | -1.43% | 6,405 | 858.00K |
| 404 | ATYR | aTyr Pharma, Inc. | 72.56M | -22.12% | 907,875 | 190.00K |
| 405 | OSTX | OS Therapies Incorporated | 72.10M | 0.29% | 27,851 | - |
| 406 | PDSB | PDS Biotechnology Corporation | 70.89M | -2.31% | 86,868 | - |
| 407 | ACTU | Actuate Therapeutics, Inc. | 70.14M | -0.57% | 10,213 | - |
| 408 | MNOV | MediciNova, Inc. | 69.15M | -0.36% | 18,892 | 409.66K |
| 409 | TCRX | TScan Therapeutics, Inc. | 67.61M | -4.66% | 437,321 | 9.14M |
| 410 | KALA | KALA BIO, Inc. | 66.92M | -7.93% | 11,586 | - |
| 411 | IBO | Impact BioMedical Inc. | 64.80M | -3.84% | 10,907 | 32.00K |
| 412 | IMMP | Immutep Limited | 63.11M | 2.41% | 147,064 | 5.28M |
| 413 | HYFT | MindWalk Holdings Corp. | 62.58M | -4.55% | 32,192 | 20.70M |
| 414 | IMA | ImageneBio, Inc. | 61.85M | -1.43% | 389 | 800.00K |
| 415 | BYSI | BeyondSpring Inc. | 61.27M | -1.97% | 182 | 1.88M |
| 416 | FLNA | Filana Therapeutics, Inc. | 60.87M | -1.56% | 29,379 | - |
| 417 | CING | Cingulate Inc. | 60.15M | -1.01% | 82,753 | - |
| 418 | IBIO | iBio, Inc. | 58.91M | -1.81% | 30,955 | 300.00K |
| 419 | LIXT | Lixte Biotechnology Holdings, Inc. | 57.86M | -3.30% | 727 | - |
| 420 | ENTX | Entera Bio Ltd. | 57.35M | 5.13% | 11,224 | 42.00K |
| 421 | DWTX | Dogwood Therapeutics, Inc. | 56.45M | - | 3,121 | - |
| 422 | INKT | MiNK Therapeutics, Inc. | 55.87M | 2.74% | 7,389 | - |
| 423 | TIL | Instil Bio, Inc. | 55.14M | 1.16% | 67 | - |
| 424 | KZR | Kezar Life Sciences, Inc. | 53.86M | -0.95% | 616,015 | - |
| 425 | ESLA | Estrella Immunopharma, Inc. | 53.76M | -1.59% | 735 | - |
| 426 | HYPD | Hyperion DeFi, Inc. | 51.14M | -0.83% | 30,611 | 813.46K |
| 427 | MGX | Metagenomi Therapeutics, Inc. | 50.45M | -0.74% | 68,657 | 22.33M |
| 428 | RADX | Radiopharm Theranostics Limited | 48.88M | - | 9,769 | 10.86M |
| 429 | XLO | Xilio Therapeutics, Inc. | 46.49M | 0.52% | 4,113 | 43.77M |
| 430 | ATOS | Atossa Therapeutics, Inc. | 46.07M | -2.73% | 12,521 | - |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 44.01M | -0.78% | 28,907 | - |
| 432 | LITS | Lite Strategy, Inc. | 43.63M | -3.23% | 58,499 | - |
| 433 | NTRB | Nutriband Inc. | 42.55M | -4.11% | 1,793 | 2.04M |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 42.14M | 0.88% | 21,281 | 90.00K |
| 435 | PSTV | Plus Therapeutics, Inc. | 40.90M | -1.32% | 13,833 | 5.21M |
| 436 | RNXT | RenovoRx, Inc. | 38.75M | 1.18% | 8,901 | 1.12M |
| 437 | ALGS | Aligos Therapeutics, Inc. | 38.70M | 0.72% | 8,575 | 4.71M |
| 438 | MREO | Mereo BioPharma Group plc | 38.31M | -1.03% | 240,677 | 500.00K |
| 439 | TVRD | Tvardi Therapeutics, Inc. | 36.59M | -1.52% | 1,158 | - |
| 440 | PTN | Palatin Technologies, Inc. | 36.56M | -1.00% | 1,114 | 8.96M |
| 441 | EVAX | Evaxion A/S | 36.20M | 2.72% | 5,168 | 7.53M |
| 442 | GRCE | Grace Therapeutics, Inc. | 35.59M | -2.13% | 24,727 | - |
| 443 | VERU | Veru Inc. | 35.55M | 0.23% | 10,928 | 16.89M |
| 444 | PLUR | Pluri Inc. | 35.38M | - | 716 | 1.34M |
| 445 | INMB | INmune Bio Inc. | 35.36M | -1.48% | 13,217 | 50.00K |
| 446 | NXTC | NextCure, Inc. | 35.28M | - | 475 | - |
| 447 | CRVO | CervoMed Inc. | 34.91M | -0.79% | 1,737 | 4.01M |
| 448 | BOLD | Boundless Bio, Inc. | 34.75M | 0.65% | 14,861 | - |
| 449 | DARE | Daré Bioscience, Inc. | 34.21M | -6.75% | 97,904 | 1.03M |
| 450 | APLM | Apollomics, Inc. | 32.17M | 2.59% | 48 | 8.84M |
| 451 | NNVC | NanoViricides, Inc. | 31.74M | -1.34% | 34,470 | - |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 31.15M | -1.95% | 14,094 | 22.00K |
| 453 | HOWL | Werewolf Therapeutics, Inc. | 31.14M | -3.00% | 77,539 | 1.14M |
| 454 | SKYE | Skye Bioscience, Inc. | 30.50M | -1.34% | 14,723 | - |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 30.05M | 1.80% | 4,508 | - |
| 456 | BCTX | BriaCell Therapeutics Corp. | 30.03M | -1.92% | 8,937 | - |
| 457 | PLRZ | Polyrizon Ltd. | 29.97M | -0.68% | 1,765 | - |
| 458 | QNTM | Quantum BioPharma Ltd. | 29.86M | - | 7,388 | - |
| 459 | IGC | IGC Pharma, Inc. | 29.85M | -0.30% | 22,536 | 1.11M |
| 460 | LSTA | Lisata Therapeutics, Inc. | 28.90M | -1.84% | 147 | 170.00K |
| 461 | SNSE | Sensei Biotherapeutics, Inc. | 28.82M | 3.72% | 2,103 | - |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 28.15M | -3.43% | 624 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 27.98M | - | 753 | 14.97M |
| 464 | KYNB | Kyntra Bio, Inc. | 27.89M | 1.32% | 630 | 7.44M |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 27.66M | -0.77% | 4,446 | 14.99M |
| 466 | TPST | Tempest Therapeutics, Inc. | 27.54M | -1.03% | 3,553 | - |
| 467 | DYAI | Dyadic International, Inc. | 27.18M | 3.01% | 6,753 | 3.09M |
| 468 | JSPR | Jasper Therapeutics, Inc. | 26.35M | -0.12% | 5,051 | - |
| 469 | ABVC | ABVC BioPharma, Inc. | 25.45M | 0.98% | 4,686 | 797.92K |
| 470 | ALLR | Allarity Therapeutics, Inc. | 25.05M | -3.57% | 72,577 | 320.00K |
| 471 | OTLK | Outlook Therapeutics, Inc. | 24.87M | -4.03% | 209,726 | 205.70K |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 24.67M | -7.57% | 5,094,464 | 789.00K |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.34M | 0.69% | 4,078 | 3.55M |
| 474 | LTRN | Lantern Pharma Inc. | 23.99M | 2.39% | 17,133 | - |
| 475 | SER | Serina Therapeutics, Inc. | 23.75M | -0.38% | 27,085 | 130.00K |
| 476 | AEON | AEON Biopharma, Inc. | 23.68M | 2.04% | 8,162 | - |
| 477 | CELU | Celularity Inc. | 23.50M | 5.84% | 16,240 | 26.55M |
| 478 | LGVN | Longeveron Inc. | 23.42M | -4.52% | 76,078 | 1.20M |
| 479 | VYNE | VYNE Therapeutics Inc. | 21.99M | -0.68% | 34,707 | 570.00K |
| 480 | CRIS | Curis, Inc. | 21.99M | -0.16% | 32,130 | 9.44M |
| 481 | XCUR | Exicure, Inc. | 20.72M | -3.85% | 2,287 | 500.00K |
| 482 | GRDX | GridAI Technologies Corp. | 20.21M | 2.19% | 2,399 | - |
| 483 | QNCX | Quince Therapeutics, Inc. | 20.13M | -0.40% | 106,580 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 19.82M | 0.47% | 2,816 | - |
| 485 | LPCN | Lipocine Inc. | 18.78M | 0.86% | 24,066 | 2.00M |
| 486 | TRAW | Traws Pharma, Inc. | 18.69M | -8.91% | 701,166 | 2.79M |
| 487 | ICU | SeaStar Medical Holding Corporation | 18.35M | 0.22% | 1,653 | 1.23M |
| 488 | COCP | Cocrystal Pharma, Inc. | 17.92M | - | 3,299 | - |
| 489 | OSRH | OSR Holdings, Inc. | 17.69M | -5.97% | 427,732 | 2.91M |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 16.87M | -0.77% | 7,963 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 16.74M | -3.30% | 41,811 | 3.94M |
| 492 | INAB | IN8bio, Inc. | 16.00M | -0.31% | 491 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 15.62M | 4.17% | 8,175 | 368.00K |
| 494 | TOVX | Theriva Biologics, Inc. | 15.42M | -1.47% | 373,171 | 300.00K |
| 495 | GNTA | Genenta Science S.p.A. | 14.90M | 0.29% | 18,548 | - |
| 496 | NCEL | NewcelX Ltd. | 14.86M | -2.69% | 570 | - |
| 497 | PASG | Passage Bio, Inc. | 14.63M | 3.64% | 64,903 | - |
| 498 | HIND | Vyome Holdings, Inc. | 14.11M | 2.03% | 181,191 | 319.71K |
| 499 | BLRX | BioLineRx Ltd. | 13.50M | 3.52% | 273 | 1.18M |
| 500 | INTS | Intensity Therapeutics, Inc. | 13.33M | 0.64% | 14,114 | - |